Public Health | November 10, 2021
Takeda receives the Arogaya CIBioD Leadership Award
It was recognized for its holistic initiatives designed to improve the quality of life and standards of care for patients
It was recognized for its holistic initiatives designed to improve the quality of life and standards of care for patients
All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for WHO
The collaboration will combine Metagenomi’s next-generation CRISPR-based and other novel gene editing systems with Moderna’s mRNA and LNP technologies
New bioinformatic workflow advances analysis capabilities for whole-exome assessment and interpretation
The company is a medical dictation solution used by medical practitioners
The acquisition expands Takeda’s immuno-oncology and innate immune cell therapy portfolio with novel platforms leveraging T cells for the potential treatment of solid tumours and haematological malignancies
Its unique technology, ChetoSensar gives new promise to ADCs by alleviating solubility challenges
The collaboration provides KardiaMobile users quick access to doctors worldwide for consultations about their ECG readings
The Phase 3 study is designed to bridge data collected from the vaccine efficacy trial conducted in India to the U.S. population
Subscribe To Our Newsletter & Stay Updated
